Jefferies Lifts Est./PT on Abbott Labs (ABT) after In-Line Q1
Tweet Send to a Friend
Jefferies raised estimates and its price target on Abbott Labs (NYSE: ABT) from $42 to $43 following Q1 results.
This article: 135 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 135 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
